Lazard Asset Management LLC Regenxbio Inc. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 7,630 shares of RGNX stock, worth $77,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,630
Previous 119 6311.76%
Holding current value
$77,444
Previous $1,000 7900.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.49 - $14.39 $78,790 - $108,083
7,511 Added 6311.76%
7,630 $80,000
Q2 2024

Aug 14, 2024
SELL
$11.51 - $21.53 $19,014 - $35,567
-1,652 Reduced 93.28%
119 $1,000
Q1 2024

May 14, 2024
SELL
$12.17 - $24.61 $118,487 - $239,602
-9,736 Reduced 84.61%
1,771 $36,000
Q4 2023

Feb 14, 2024
BUY
$12.89 - $20.82 $114,940 - $185,651
8,917 Added 344.29%
11,507 $206,000
Q3 2023

Nov 14, 2023
BUY
$16.46 - $19.99 $1,761 - $2,138
107 Added 4.31%
2,590 $42,000
Q2 2023

Aug 14, 2023
SELL
$17.23 - $21.71 $62,562 - $78,829
-3,631 Reduced 59.39%
2,483 $49,000
Q1 2023

May 15, 2023
SELL
$18.08 - $24.55 $56,228 - $76,350
-3,110 Reduced 33.72%
6,114 $114,000
Q4 2022

Feb 14, 2023
SELL
$20.4 - $24.73 $20,950 - $25,397
-1,027 Reduced 10.02%
9,224 $209,000
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $11,256 - $17,695
505 Added 5.18%
10,251 $270,000
Q2 2022

Aug 09, 2022
BUY
$19.35 - $35.04 $61,107 - $110,656
3,158 Added 47.94%
9,746 $240,000
Q1 2022

May 13, 2022
BUY
$24.62 - $34.31 $111,971 - $156,041
4,548 Added 222.94%
6,588 $218,000
Q4 2021

Feb 09, 2022
SELL
$30.19 - $40.28 $54,311 - $72,463
-1,799 Reduced 46.86%
2,040 $66,000
Q3 2021

Nov 15, 2021
BUY
$29.09 - $45.68 $37,613 - $59,064
1,293 Added 50.79%
3,839 $160,000
Q2 2021

Aug 12, 2021
BUY
$32.46 - $40.48 $80,955 - $100,957
2,494 Added 4796.15%
2,546 $98,000
Q1 2021

May 14, 2021
SELL
$33.61 - $49.95 $57,372 - $85,264
-1,707 Reduced 97.04%
52 $1,000
Q4 2020

Feb 11, 2021
BUY
$26.52 - $49.35 $9,441 - $17,568
356 Added 25.37%
1,759 $79,000
Q3 2020

Nov 13, 2020
SELL
$27.01 - $40.26 $15,368 - $22,907
-569 Reduced 28.85%
1,403 $38,000
Q2 2020

Aug 13, 2020
BUY
$27.75 - $43.44 $54,723 - $85,663
1,972 New
1,972 $72,000
Q1 2020

May 14, 2020
SELL
$21.5 - $54.2 $32,164 - $81,083
-1,496 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$34.54 - $44.87 $51,671 - $67,125
1,496 New
1,496 $61,000
Q3 2018

Nov 13, 2018
SELL
$65.0 - $82.15 $1.23 Million - $1.56 Million
-18,932 Closed
0 $0
Q2 2018

Aug 13, 2018
BUY
$27.2 - $74.35 $514,950 - $1.41 Million
18,932 New
18,932 $1.36 Million

Others Institutions Holding RGNX

# of Institutions
197
Shares Held
43.2M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $439M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email